Viatris Inc.
16.50USD
-0.1100 (-0.66%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.65▲ | $0.65 | 3 | 3 |
| Next quarter | $0.58▼ | $0.62 | 1 | 5 |
| Current year | $2.51▲ | $2.47 | 5 | 0 |
| Next year | $2.67▼ | $2.68 | 3 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.6 | $0.69 | +0.09 (+15.0%) |
| 2026-03-31 | $0.5 | $0.59 | +0.09 (+17.5%) |
| 2025-12-31 | $0.53 | $0.57 | +0.04 (+7.4%) |
| 2025-09-30 | $0.62 | $0.67 | +0.05 (+8.5%) |
49 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated | Outperform | $20 | Sep 9, 2026 |
| Argus Research | Maintained | Buy | $15 $20 | Sep 8, 2026 |
| Barclays | Maintained | Overweight | $17 $22 | May 19, 2026 |
| JP Morgan | Maintained | Neutral | $17 $18 | May 8, 2026 |
| Truist Securities | Maintained | Buy | $18 $20 | May 8, 2026 |
| Barclays | Maintained | Overweight | $15 $17 | Mar 24, 2026 |
| Piper Sandler | Maintained | Neutral | $9 $12 | Jan 28, 2026 |
| Argus Research | Upgraded from Hold | Buy | $15 | Jan 16, 2026 |
| Barclays | Initiated | Overweight | $15 | Dec 9, 2025 |
| Truist Securities | Initiated | Buy | $15 | Oct 15, 2025 |
| Goldman Sachs | Initiated | Neutral | $10 | Jun 6, 2025 |
| Jefferies | Maintained | Buy | $15 $13 | Mar 7, 2025 |
| Piper Sandler | Reiterated | Neutral | $14 $10 | Mar 5, 2025 |
| Barclays | Maintained | Underweight | $12 $9 | Feb 28, 2025 |
| B of A Securities | Maintained | Underperform | $11 $10 | Feb 28, 2025 |
| Piper Sandler | Reiterated | Neutral | $13 $14 | Dec 6, 2024 |
| Barclays | Maintained | Underweight | $11 $12 | Nov 8, 2024 |
| Piper Sandler | Reiterated | Neutral | $11 $13 | Mar 28, 2024 |
| Piper Sandler | Maintained | Neutral | $10 $11 | Nov 22, 2023 |
| B of A Securities | Downgraded from Neutral | Underperform | $9 | Oct 23, 2023 |
| Barclays | Downgraded from Equal-Weight | Underweight | $11 | Jun 23, 2023 |
| Barclays | Downgraded from Overweight | Equal-Weight | $16 $11 | Apr 25, 2023 |
| Barclays | Downgraded from Overweight | Equal-Weight | $11 | Apr 24, 2023 |
| Barclays | Maintained | Overweight | $15 $16 | Feb 28, 2023 |
| BMO Capital | Downgraded from Outperform | Market Perform | $16 $14 | Feb 17, 2023 |
No analyst notes on VTRS yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 4 | 4 | 0 | 1 | Hold2.60 |
| 1 mo ago | 1 | 4 | 4 | 0 | 1 | Hold2.60 |
| 2 mo ago | 1 | 4 | 4 | 0 | 1 | Hold2.60 |
| 3 mo ago | 1 | 4 | 4 | 0 | 1 | Hold2.60 |